Elanco Animal Health Inc
ELANNYSECIK 1739104HealthcareFiscal year ends Dec 31
Reports and events: 168 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0513:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001739104-26-000043 |
| 2026-08-0510:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-26-000040 |
| 2026-05-2721:00 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-067002 |
| 2026-05-0613:04 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001739104-26-000030 |
| 2026-05-0610:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-26-000027 |
| 2026-04-0814:07 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001739104-26-000016 |
| 2026-02-2414:19 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001739104-26-000012 |
| 2026-02-2411:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-26-000008 |
| 2026-01-1213:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002723 |
| 2025-12-0912:45 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-119486 |
| 2025-11-0514:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001739104-25-000071 |
| 2025-11-0511:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-25-000068 |
| 2025-11-0312:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-105246 |
| 2025-08-0713:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001739104-25-000055 |
| 2025-08-0710:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-25-000052 |
| 2025-06-2620:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-063027 |
| 2025-05-2811:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-053305 |
| 2025-05-2122:42 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-051136 |
| 2025-05-0713:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001739104-25-000042 |
| 2025-05-0710:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-25-000040 |
| 2025-03-2716:21 ET | DEF 14A | Proxy statementPeriod 2025-05-16 | 0001739104-25-000030 |
| 2025-03-1720:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-024432 |
| 2025-02-2514:12 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001739104-25-000014 |
| 2025-02-2512:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-25-000011 |
| 2025-01-1313:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-002881 |
| 2024-11-1222:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-116942 |
| 2024-11-0714:07 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001739104-24-000039 |
| 2024-11-0711:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-24-000036 |
| 2024-10-1610:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001104659-24-108914 |
| 2024-08-1320:32 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-089000 |
| 2024-08-0813:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001739104-24-000027 |
| 2024-08-0810:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-24-000025 |
| 2024-07-0912:30 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-078464 |
| 2024-07-0321:23 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-077840 |
| 2024-06-0420:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-068253 |
| 2024-05-0813:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001739104-24-000018 |
| 2024-05-0810:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-24-000016 |
| 2024-04-1912:00 ET | DEF 14A | Proxy statementPeriod 2024-05-30 | 0001140361-24-020680 |
| 2024-04-0112:25 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-041558 |
| 2024-02-2614:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001739104-24-000009 |
| 2024-02-2611:30 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001739104-24-000004 |
| 2024-02-0511:40 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-010337 |
| 2024-01-0822:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-002283 |
| 2024-01-0214:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-000140 |
| 2023-11-0721:14 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001739104-23-000023 |
| 2023-11-0711:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-23-000021 |
| 2023-10-0411:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-106600 |
| 2023-08-0720:11 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001739104-23-000013 |
| 2023-08-0710:30 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-23-088037 |
| 2023-07-1321:27 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-080837 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.